hospital covid-19 death patient

Study calls into question use of malaria drug for COVID-19

Reading now: 584
www.cidrap.umn.edu

A retrospective study of patients with COVID-19 at Veterans Affairs (VA) hospitals found no evidence that the anti-malaria drug hydroxychloroquine, either with or without the antibiotic azithromycin, reduced mortality or the need for mechanical ventilation.Researchers also found that hydroxychloroquine alone was associated with increased mortality.The findings, published this week on the preprint server medRxiv, suggest hydroxychloroquine may not have as much promise for treating COVID-19 patients as initially hoped.

The study was not a randomized controlled trial, so the implications of the findings are limited, and the results have not been peer-reviewed.

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA